It is a dual agonist of GIP and GLP-1 receptors. The specific indication depends on the clinical situation and the authorised technical SmPC.

Yes. Tirzepatide is subject to prescription. The consultation does not guarantee a prescription: the doctor decides according to the indication and safety.

They are different active ingredients. Semaglutide acts on the Tirzepatide receptor; Tirzepatide acts on GIP and Tirzepatide. The choice requires evaluating history, tolerance, current medication and objectives.

There is no guaranteed result. The response varies depending on the indicated treatment, the tolerated dose, time, diet, physical activity and medical circumstances of each person.

The duration is individual. The doctor reviews effectiveness, tolerance and safety before maintaining, adjusting or changing the plan.

Nausea, diarrhea, constipation, vomiting or abdominal discomfort may appear, especially when starting or increasing the dose. Intense or persistent symptoms require medical evaluation.

Seek urgent care for severe and persistent abdominal pain, repeated vomiting with inability to hydrate, allergic reaction, respiratory distress, or significant worsening.

No. The online consultation costs 39€; The medication, if prescribed, is paid for separately at the pharmacy.

The price may depend on the presentation and applicable regulations, and the stock varies by pharmacy. The prescription does not reserve units; It is advisable to confirm availability and price with an authorised pharmacy.

No. In Portugal it is not legal to sell prescription medications online. Use an authorised pharmacy and avoid offers without health control.

Don’t change on your own. The doctor must review the indication, previous dose, tolerance and appropriate timing to reduce risks.

Yes. The initial assessment can be carried out remotely. If an examination or tests are needed, your doctor will explain the next step.